Androgens stimulate telomerase expression, activity and phosphorylation in ovarian adenocarcinoma cells

Molecular and Cellular Endocrinology

Volumn 330, Issue 1-2, 2010, Pages 10-16

  Nourbakhsh, Mitra ^a   Golestani, Abolfazl ^a   Zahrai, Mahin ^a   Modarressi, Mohammad Hossein ^a   Malekpour, Zahra ^a   Karami Tehrani, Fatemeh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Androgens; Ovarian cancer; Telomerase

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; ESTRADIOL; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE; TESTOSTERONE;

ARTICLE; CARCINOGENESIS; CARCINOMA CELL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FEMALE; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ADENOCARCINOMA; ANDROGENS; ANDROSTENEDIONE; CELL LINE, TUMOR; CELL SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASE; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RNA, MESSENGER; TELOMERASE; TESTOSTERONE;

EID: 77957664583     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.07.021     Document Type: Article

References (44)

1. Baron S.r., Manin M.l., Beaudoin C., Leotoing L., Communal Y., Veyssiere G., Morel L. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J. Biol. Chem. 2004, 279:14579-14586.
2. Bertuch A.A., Buckley K., Lundblad V. The way to the end matters-the role of telomerase in tumor progression. Cell Cycle 2003, 2:36-38.
3. Blomquist C.H., Bonenfant M., McGinley D.M., Posalaky Z., Lakatua D.J., Tuli-Puri S., Bealka D.G., Tremblay Y. Androgenic and estrogenic 17beta-hydroxysteroid dehydrogenase/17-ketosteroid reductase in human ovarian epithelial tumors: evidence for the type 1, 2 and 5 isoforms. J. Steroid Biochem. Mol. Biol. 2002, 81:343-351.
4. Bouchal J., Kolar Z., Mad'arova J., Hlobikova A., Angerer E.v. The effect of natural ligands of hormone receptors and their antagonists on telomerase activity in the androgen sensitive prostatic cancer cell line. Biochem. Pharmacol. 2002, 63:1177-1181.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
6. Bulun S., Adashi Y. The physiology and pathology of the female reproductive axis. Williams Textbook of Endocrinology 2008, 541-614. Saunders, Philadelphia. S. Melmed, H. Kronenberg, K. Polonsky, P.R. Larsen (Eds.).
7. Calado R.T., Yewdell W.T., Wilkerson K.L., Regal J.A., Kajigaya S., Stratakis C.A., Young N.S. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells. Blood 2009, 114:2236-2243.
8. Cannistra S.A. Cancer of the ovary. N. Engl. J. Med. 2004, 351:2519-2529.
9. Cardillo M.R., Petrangeli E., Aliotta N., Salvatori L., Ravenna L., Chang C., Castagna G. Androgen receptors in ovarian tumors: correlation with oestrogen and progesterone receptors in an immunohistochemical and semiquantitative image analysis study. J. Exp. Clin. Cancer Res. 1998, 17:231-237.
10. Cho K.R. Ovarian cancer update: lessons from morphology, molecules, and mice. Arch. Pathol. Lab. Med. 2009, 133:1775-1781.
11. Chura J.C., Ryu H.S., Simard M., Poirier D., Tremblay Y., Brooker D.C., Blomquist C.H., Argenta P.A. Steroid-converting enzymes in human ovarian carcinomas. Mol. Cell. Endocrinol. 2009, 301:51-58.
12. Cong Y.S., Wright W.E., Shay J.W. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 2002, 66:407-425.
13. Cukusic A., Skrobot Vidacek N., Sopta M., Rubelj I. Telomerase regulation at the crossroads of cell fate. Cytogenet. Genome Res. 2008, 122:263-272.
14. Datar R.H., Naritoku W.Y., Li P., Tsao-Wei D., Groshen S., Taylor C.R., Imam S.A. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas. Gynecol. Oncol. 1999, 74:338-345.
15. Dizon D.S., Tejada-Berges T., Koelliker S., Steinhoff M., Granai C.O. Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient. Gynecol. Obstet. Invest. 2006, 62:226-228.
16. Edmondson R.J., Monaghan J.M., Davies B.R. The human ovarian surface epithelium is an androgen responsive tissue. Br. J. Cancer 2002, 86:879-885.
17. Guo C., Armbruster B.N., Price D.T., Counter C.M. In vivo regulation of hTERT expression and telomerase activity by androgen. J. Urol. 2003, 170:615-618.
18. Hage J.J., Dekker J.J., Karim R.B., Verheijen R.H., Bloemena E. Ovarian cancer in female-to-male transsexuals: report of two cases. Gynecol. Oncol. 2000, 76:413-415.
19. Hahn W.C. Role of telomeres and telomerase in the pathogenesis of human cancer. J. Clin. Oncol. 2003, 21:2034-2043.
20. Harrington L. Biochemical aspects of telomerase function. Cancer Lett. 2003, 194:139-154.
21. Helzlouser K.J., Alberg A.J., Gordon G.B., Longcope C., Bush T., Hoffman S.C. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995, 274:1926-1930.
22. Horikawa I., Barrett J.C. Transcriptional regulation of the telomerase hTERT gene as a target for cellular and viral oncogenic mechanisms. Carcinogenesis 2003, 24:1167-1176.
23. Iczkowski K.A., Huang W., Mazzucchelli R., Pantazis C.G., Stevens G.R., Montironi R. Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT. Cancer 2004, 100:294-299.
24. Kang S.S., Kwon T., Kwon D.Y., Do S.I. Akt Protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J. Biol. Chem. 1999, 274:13085-13090.
25. Kimura A., Ohmichi M., Kawagoe J., Kyo S., Mabuchi S., Takahashi T., Ohshima C., Arimoto-Ishida E., Nishio Y., Inoue M., Kurachi H., Tasaka K., Murata Y. Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell lines. Oncogene 2004, 23:4505-4515.
26. Kirschenbaum A., Liu X.H., Yao S., Narla G., Friedman S.L., Martignetti J.A., Levine A.C. Sex steroids have differential effects on growth and gene expression in primary human prostatic epithelial cell cultures derived from the peripheral versus transition zones. Carcinogenesis 2006, 27:216-224.
27. Li H., Zhao L.L., Funder J.W., Liu J.P. Protein phosphatase 2A inhibits nuclear telomerase activity in human breast cancer cells. J. Biol. Chem. 1997, 272:16729-16732.
28. Liu K., Hodes R.J., Weng N.-p. Cutting edge: telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J. Immunol. 2001, 166:4826-4830.
29. Meeker A.K., Sommerfeld H.J., Coffey D.S. Telomerase is activated in the prostate and seminal vesicles of the castrated rat. Endocrinology 1996, 137:5743-5746.
30. Plunkett F.J., Franzese O., Finney H.M., Fletcher J.M., Belaramani L.L., Salmon M., Dokal I., Webster D., Lawson A.D., Akbar A.N. The loss of telomerase activity in highly differentiated CD8+CD28-CD27- T cells is associated with decreased Akt (Ser473) phosphorylation. J. Immunol. 2007, 178:7710-7719.
31. Ravindranath N., Ioffe S.L., Marshall G.R., Ramaswamy S., Plant T.M., Dym M. Androgen depletion activates telomerase in the prostate of the nonhuman primate, Macaca mulatta. Prostate 2001, 49:79-89.
32. Rinaldi S., Dossus L., Lukanova A., Peeters P.H., Allen N.E., Key T., Bingham S., Khaw K.T., Trichopoulos D., Trichopoulou A., Oikonomou E., Pera G., Larranaga N., Martinez-Garcia C., Ardanaz E., Quiros J.R., Tormo M.J., Tjonneland A., Olsen A., Overvad K., Chang-Claude J., Linseisen J., Schulz M., Boeing H., van Gils C.H., Bueno-de-Mesquita B.H., Pala V., Palli D., Panico S., Tumino R., Vineis P., Clavel-Chapelon F., Mesrine S., Boutron-Ruault M.C., Lundin E., Agren A., Berglund G., Manjer J., Kumle M., Lund E., Slimani N., Saracci R., Riboli E., Kaaks R. Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol. Biomarkers Prev. 2007, 16:23-29.
33. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J. Natl. Cancer Inst. 1998, 90:1774-1786.
34. Roett M.A., Evans P. Ovarian cancer: an overview. Am. Fam. Phys. 2009, 80:609-616.
35. Schildkraut J., Schwingl P.J., Bastos E., Evanoff A., Hughes C. Epithelial ovarian cancer risk among women with polysystic ovarian syndrome. Obstet. Gynecol. 1996, 88:554-559.
36. Shayesteh L., Lu Y., Kuo W.L., Baldocchi R., Godfrey T., Collins C., Pinkel D., Powell B., Mills G.B., Gray J.W. PIK3CA is implicated as an oncogene in ovarian cancer. Nat. Genet. 1999, 21:99-102.
37. Sheach L.A., Adeney E.M., Kucukmetin A., Wilkinson S.J., Fisher A.D., Elattar A., Robson C.N., Edmondson R.J. Androgen-related expression of G-proteins in ovarian cancer. Br. J. Cancer 2009, 101:498-503.
38. Shin J.-S., Hong A., Solomon M.J., Lee C.S. The role of telomeres and telomerase in the pathology of human cancer and aging. Pathology 2006, 38:103-113.
39. Silva E.G., Tornos C., Fritsch H.A.J. The induction of benign epithelial neoplasms of the ovaries of guinea pigs by testosterone stimulation: a potential animal model. Mod. Pathol. 1997, 10:879-883.
40. Soda H., Raymond E., Sharma S., Lawrence R., Davidson K., Oka M., Kohno S., Izbicka E., Hoff D.D.V. Effects of Androgens on telomerase activity in normal and malignant prostate cells in vitro. Prostate 2000, 43:161-168.
41. Tworoger S.S., Lee I.M., Buring J.E., Hankinson S.E. Plasma androgen concentrations and risk of incident ovarian cancer. Am. J. Epidemiol. 2008, 167:211-218.
42. Verhoeven G., Swinnen J.V. Indirect mechanisms and cascades of androgen action. Mol. Cell. Endocrinol. 1999, 151:205-212.
43. Wong A.S.T., Kim S.O., Leung P.C.K., Auersperg N., Pelech S.L. Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium. Gynecol. Oncol. 2001, 82:305-311.
44. Yuan Z.Q., Sun M., Feldman R.I., Wang G., Ma X., Jiang C., Coppola D., Nicosia S.V., Cheng J.Q. Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene 2000, 19:2324-2330.